Hepatitis C during pregnancy, vertical transmission and new treatment possibilities
Copyright © 2016 Elsevier España, S.L.U. All rights reserved..
Hepatitis C virus (HCV) infection has been recognised as a worldwide health problem. HCV is the most common cause of cirrhosis, hepatocellular carcinoma and liver transplantation. The HCV prevalence reported in pregnant women is similar to that found among the general population and does not appear to have an adverse effect on the course of pregnancy. The vertical transmission of HCV (HCV-VT) is a major route of HCV infection in children in the developed countries (>90%). The overall rate of mother-to-child transmission and chronification is about 3%-8%; however, this rate is higher for mothers who are co-infected with the human immunodeficiency virus (15-20%). In this review, we analyse the course of HCV infection during gestation, the risk factors associated with HCV-VT, the diagnostic methods/clinical monitoring recommended and the new possibilities of treatment in the era of direct-acting antiviral agents, which are essential to guide future public health efforts appropriately.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:147 |
|---|---|
| Enthalten in: |
Medicina clinica - 147(2016), 11 vom: 02. Dez., Seite 499-505 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Hepatitis C durante la gestación, transmisión vertical y nuevas posibilidades de tratamiento |
|---|
| Beteiligte Personen: |
Muñoz-Gámez, José Antonio [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 22.11.2017 Date Revised 28.11.2017 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.medcli.2016.04.003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM260606685 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM260606685 | ||
| 003 | DE-627 | ||
| 005 | 20231224193747.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.1016/j.medcli.2016.04.003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0868.xml |
| 035 | |a (DE-627)NLM260606685 | ||
| 035 | |a (NLM)27209226 | ||
| 035 | |a (PII)S0025-7753(16)30075-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Muñoz-Gámez, José Antonio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hepatitis C during pregnancy, vertical transmission and new treatment possibilities |
| 246 | 3 | 3 | |a Hepatitis C durante la gestación, transmisión vertical y nuevas posibilidades de tratamiento |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.11.2017 | ||
| 500 | |a Date Revised 28.11.2017 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2016 Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a Hepatitis C virus (HCV) infection has been recognised as a worldwide health problem. HCV is the most common cause of cirrhosis, hepatocellular carcinoma and liver transplantation. The HCV prevalence reported in pregnant women is similar to that found among the general population and does not appear to have an adverse effect on the course of pregnancy. The vertical transmission of HCV (HCV-VT) is a major route of HCV infection in children in the developed countries (>90%). The overall rate of mother-to-child transmission and chronification is about 3%-8%; however, this rate is higher for mothers who are co-infected with the human immunodeficiency virus (15-20%). In this review, we analyse the course of HCV infection during gestation, the risk factors associated with HCV-VT, the diagnostic methods/clinical monitoring recommended and the new possibilities of treatment in the era of direct-acting antiviral agents, which are essential to guide future public health efforts appropriately | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Antivirales de acción directa | |
| 650 | 4 | |a Direct-acting antiviral agents | |
| 650 | 4 | |a Factores de riesgo | |
| 650 | 4 | |a Gestación | |
| 650 | 4 | |a Hepatitis C virus | |
| 650 | 4 | |a Pregnancy | |
| 650 | 4 | |a Risk factors | |
| 650 | 4 | |a Transmisión vertical | |
| 650 | 4 | |a Vertical transmission | |
| 650 | 4 | |a Virus de la hepatitis C | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 700 | 1 | |a Salmerón, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Ruiz-Extremera, Ángeles |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medicina clinica |d 1948 |g 147(2016), 11 vom: 02. Dez., Seite 499-505 |w (DE-627)NLM000359017 |x 1578-8989 |7 nnns |
| 773 | 1 | 8 | |g volume:147 |g year:2016 |g number:11 |g day:02 |g month:12 |g pages:499-505 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.medcli.2016.04.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 147 |j 2016 |e 11 |b 02 |c 12 |h 499-505 | ||